Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

How Is a MELAS Stroke Different from a Regular Stroke?

At a Glance

A MELAS stroke-like episode is caused by cellular energy failure, not a blood clot like a typical stroke. Standard stroke treatments like clot-busting drugs (tPA) are dangerous for MELAS patients. Emergency care should instead focus on administering IV L-arginine and controlling seizures.

A stroke-like episode in MELAS looks and feels like a regular stroke, but the underlying cause is completely different. While a typical stroke (ischemic stroke) happens when a blood clot blocks an artery [1][2], a MELAS episode is caused by a cellular energy failure and a lack of nitric oxide in the brain [1][2][3]. Because there is no clot to dissolve, standard stroke treatments like “clot-busting” drugs do not work for MELAS and can actually be risky [2][4][5].

The Mechanism: Energy Crisis vs. Blocked Pipes

  • Typical Ischemic Stroke: Caused by a blood clot blocking a blood vessel (thromboembolic vascular occlusion) [1][2]. This cuts off the oxygen supply to the brain tissue that relies on that specific artery.
  • MELAS Stroke-Like Episode (SLE): The root issue is not a physical blockage. Instead, the brain’s cells run out of energy because their mitochondria (the cells’ microscopic power plants) are not functioning properly [1][2]. This profound energy failure is compounded by a deficiency of nitric oxide, a natural molecule that normally helps blood vessels relax and stay open [1][3]. Without enough energy and nitric oxide, the brain tissue becomes damaged and behaves similarly to how it would during a typical stroke.

Differences on Brain Scans

When a patient goes to the emergency room, doctors use brain imaging (like an MRI) to understand what is happening. The two types of episodes show distinct patterns that help doctors make the correct diagnosis:

  • Location and Boundaries: A typical stroke damages tissue strictly within the specific area fed by the blocked blood vessel [6]. In contrast, MELAS brain lesions often cross these typical vascular boundaries [6][7]. They also frequently appear in the back of the brain, specifically in the occipital and parietal lobes [7][8][9].
  • Blood Flow Patterns: Standard strokes usually show a lack of blood flow (hypoperfusion) to the affected area [10]. Advanced imaging of a MELAS episode often reveals the opposite: increased blood flow (hyperperfusion) to the affected brain regions [2][10][11].
  • Metabolic Signs: Specialized scans (called Magnetic Resonance Spectroscopy, or MRS) often show abnormally high levels of lactate (lactic acid) in the brain tissue during a MELAS episode [12][13]. Elevated lactate serves as a key metabolic biomarker that helps doctors tell a MELAS episode apart from a typical stroke [12][13].

Why Proper Diagnosis Changes Emergency Treatment

Understanding the distinction between these two emergencies is critical for patient safety. ER doctors follow strict, time-sensitive protocols for standard strokes. To ensure the right care, patients should obtain a formal Emergency Protocol Letter from their metabolic specialist or neurologist detailing their diagnosis, the need for L-arginine, and the danger of standard stroke treatments. This letter should be handed to the triage nurse immediately upon arrival. Furthermore, family members who are known or suspected carriers should also have emergency protocols on file for sudden neurological symptoms.

However, because a patient with MELAS could theoretically still have a regular ischemic stroke, rapid advanced imaging (like MRI/MRS) to confirm the episode type is vital before proceeding with treatment.

  • Avoid “Clot-Busters” and Clot Removal: The standard emergency treatments for an ischemic stroke are a medication called tPA (tissue plasminogen activator) to dissolve clots, or sometimes surgical clot removal (mechanical thrombectomy) [2]. Because MELAS episodes are not caused by clots, these treatments are not helpful [2][6]. Giving tPA to a MELAS patient during a stroke-like episode is unnecessary and carries the risk of dangerous side effects, such as bleeding in the brain (hemorrhagic transformation) [2][5][4].
  • MELAS-Specific Management: Instead of clot-busting procedures, the medical team will focus on symptomatic and supportive care [14][15]. Doctors may administer intravenous L-arginine during an acute episode, an amino acid thought to help increase nitric oxide levels. While large clinical trials are still ongoing, L-arginine is widely considered part of the standard care for these episodes [16][17][13].
  • Seizure Control: Seizures can act as an early warning sign (prodrome) that a stroke-like episode is starting, occur during the episode, or even contribute to brain damage due to the overactivity of brain cells (neuronal hyperexcitability) [6][18]. Therefore, aggressively controlling seizures is a top priority in the emergency room [6][19]. If you or a loved one experience an unprovoked seizure, it should be treated as a medical emergency.

ER Quick Reference Guide

  • Diagnosis: MELAS Stroke-Like Episode (Mitochondrial Encephalomyopathy)
  • DO NOT administer tPA (clot-busters) or perform mechanical thrombectomy without confirmation of an ischemic clot.
  • DO order an MRI with MRS to check for elevated lactate and hyperperfusion.
  • DO administer IV L-Arginine (per metabolic specialist’s protocol).
  • DO aggressively treat any seizures.

Common questions in this guide

Why can't I receive clot-busting drugs for a MELAS stroke-like episode?
MELAS episodes are caused by a cellular energy failure and a lack of nitric oxide, rather than a physical blood clot. Giving clot-busting drugs like tPA is unnecessary and can actually increase the risk of dangerous bleeding in the brain.
How do ER doctors tell the difference between a MELAS episode and a typical stroke?
Doctors use advanced brain imaging like MRI and MRS to look for specific patterns. MELAS episodes often show increased blood flow and high levels of lactate in the brain, whereas standard strokes typically show reduced blood flow and follow typical vascular boundaries.
What is the standard treatment for a MELAS stroke-like episode?
Emergency treatment focuses on giving intravenous L-arginine to help blood vessels relax and aggressively controlling any seizures. The medical team will also provide supportive care tailored to your specific symptoms instead of focusing on clot removal.
What should my family do if I experience a stroke-like episode or unprovoked seizure?
Your family should immediately bring you to the emergency room and hand your Emergency Protocol Letter to the triage nurse. They need to clearly communicate your MELAS diagnosis so the medical team knows to avoid standard stroke treatments.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you help me draft an Emergency Protocol Letter that I can hand to ER doctors if I have an episode?
  2. 2.If I arrive at an unfamiliar ER during an episode, who is the best specialist for the ER doctors to consult with immediately?
  3. 3.Should my family members who might be carriers also carry an emergency letter just in case?
  4. 4.What specific seizure warning signs or symptoms should prompt my family to bring me straight to the hospital?
  5. 5.Are there any specific baseline imaging scans I should have done now so ER doctors have something to compare against during an emergency?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A > G mutation.

    Evangelisti S, Gramegna LL, La Morgia C, et al.

    Molecular genetics and metabolism 2022; (135(1)):72-81 doi:10.1016/j.ymgme.2021.11.012.

    PMID: 34916127
  2. 2

    Stroke-like episodes, peri-episodic seizures, and MELAS mutations.

    Finsterer J, Wakil SM

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(6)):824-829 doi:10.1016/j.ejpn.2016.08.002.

    PMID: 27562097
  3. 3

    Confirmation of stroke-like lesions on magnetic resonance imaging is a prerequisite for their histopathological assessment.

    Finsterer J

    Neuropathology : official journal of the Japanese Society of Neuropathology 2019; (39(6)):489-490 doi:10.1111/neup.12602.

    PMID: 31584210
  4. 4

    Therapeutic management of stroke-like episodes varies from that of encephalitis.

    Finsterer J

    Medicine 2020; (99(8)):e19141 doi:10.1097/MD.0000000000019141.

    PMID: 32080090
  5. 5

    Clinicoradiologic Criteria for the Diagnosis of Stroke-like Episodes in MELAS.

    Khasminsky V, Auriel E, Luckman J, et al.

    Neurology. Genetics 2023; (9(4)):e200082 doi:10.1212/NXG.0000000000200082.

    PMID: 37426458
  6. 6

    A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features.

    Hongo Y, Kaneko J, Suga H, et al.

    Journal of neurology 2019; (266(6)):1459-1472 doi:10.1007/s00415-019-09283-3.

    PMID: 30888501
  7. 7

    Imaging in Sequential Stroke-like Episodes in Adult MELAS.

    Chen T, Wilson L

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2021; (48(5)):715-716 doi:10.1017/cjn.2020.282.

    PMID: 33397536
  8. 8

    From stroke workup to mitochondrial disease: A case report of MELAS.

    Sevencan Y, Rode S, Park A, et al.

    Radiology case reports 2025; (20(12)):6248-6252 doi:10.1016/j.radcr.2025.09.031.

    PMID: 41070281
  9. 9

    MELAS Presenting as Bilateral Symmetric Occipital and Temporal Cortices Lesions: A Case Report and Literature Review.

    Liu Q, Wang Z, Shi J, et al.

    The neurologist 2025; (30(2)):75-79 doi:10.1097/NRL.0000000000000588.

    PMID: 39450883
  10. 10

    Differential diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) and ischemic stroke using 3D pseudocontinuous arterial spin labeling.

    Li R, Xiao HF, Lyu JH, et al.

    Journal of magnetic resonance imaging : JMRI 2017; (45(1)):199-206 doi:10.1002/jmri.25354.

    PMID: 27348222
  11. 11

    Migratory vasodilatation of cerebral arteries in MELAS episodes: a case report and literature review.

    Luo Y, Chu Q, Yu T, et al.

    Frontiers in immunology 2026; (17()):1706012 doi:10.3389/fimmu.2026.1706012.

    PMID: 41727454
  12. 12

    Correlation of Serum Biomarkers and Magnetic Resonance Spectroscopy in Monitoring Disease Progression in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Due to mtDNA A3243G Mutation.

    Lee HN, Yoon CS, Lee YM

    Frontiers in neurology 2018; (9()):621 doi:10.3389/fneur.2018.00621.

    PMID: 30140253
  13. 13

    MELAS: Monitoring treatment with magnetic resonance spectroscopy.

    Hovsepian DA, Galati A, Chong RA, et al.

    Acta neurologica Scandinavica 2019; (139(1)):82-85 doi:10.1111/ane.13027.

    PMID: 30216413
  14. 14

    Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Fan HC, Lee HF, Yue CT, Chi CS

    Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111111.

    PMID: 34832987
  15. 15

    Mitochondrial stroke-like episodes: The search for new therapies.

    Orsucci D, Caldarazzo Ienco E, Montano V, et al.

    Pharmacological research 2022; (180()):106228 doi:10.1016/j.phrs.2022.106228.

    PMID: 35462010
  16. 16

    l-Arginine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes: A Systematic Review.

    Stefanetti RJ, Ng YS, Errington L, et al.

    Neurology 2022; (98(23)):e2318-e2328 doi:10.1212/WNL.0000000000200299.

    PMID: 35428733
  17. 17

    Arginine for the Treatment of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes: A Systematic Review.

    Argudo JM, Astudillo Moncayo OM, Insuasti W, et al.

    Cureus 2022; (14(12)):e32709 doi:10.7759/cureus.32709.

    PMID: 36686069
  18. 18

    Long-term ketogenic diet therapy improves mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS): A case report.

    He F, Ye L, Miao P, et al.

    CNS neuroscience & therapeutics 2023; (29(9)):2717-2720 doi:10.1111/cns.14274.

    PMID: 37208962
  19. 19

    Epilepsy in MELAS.

    Finsterer J, Zarrouk-Mahjoub S

    Pediatric neurology 2017; (67()):e7-e8 doi:10.1016/j.pediatrneurol.2016.10.015.

    PMID: 27867040

This page is for informational purposes only and does not replace professional medical advice. Always carry an Emergency Protocol Letter and consult your neurologist or metabolic specialist for your specific emergency plans.

Get notified when new evidence is published on MELAS.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.